ProShare Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $597K | Buy |
|
|||||
|
2023
Q1 | $498K | Sell |
|
|||||
|
2022
Q4 | $235K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $276K | Sell |
|
|||||
|
2021
Q4 | $275K | Buy |
|
|||||
|
2021
Q3 | $1.03M | Sell |
|
|||||
|
2021
Q2 | $1.81M | Buy |
|
|||||
|
2021
Q1 | $428K | Sell |
|
|||||
|
2020
Q4 | $550K | Sell |
|
|||||
|
2020
Q3 | $448K | Buy |
|
|||||
|
2020
Q2 | $702K | Sell |
|
|||||
|
2020
Q1 | $738K | Sell |
|
|||||
|
2019
Q4 | $1.84M | Buy |
|
|||||
|
2019
Q3 | $716K | Sell |
|
|||||
|
2019
Q2 | $861K | Sell |
|
|||||
|
2019
Q1 | $875K | Buy |
|
|||||
|
2018
Q4 | $567K | Sell |
|
|||||
|
2018
Q3 | $978K | Buy |
|
|||||
|
2018
Q2 | $370K | Sell |
|
|||||
|
2018
Q1 | $218K | Sell |
|
|||||
|
2017
Q4 | $350K | Buy |
|